Yom Chai Forms Strategic Partnership With Israeli Research and Development Company Kaneh-B to Conduct Scientific Clinical Trials on ADHD and to Distribute Approved European Dermal Products to Market

Wednesday, October 3, 2018 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

TEL AVIV, Israel, October 3, 2018 /PRNewswire/ --

Yom Chai is pleased to announce that it has entered into a strategic

partnership with Kaneh-B to co-found the development and clinical validation of a range of cannabis based ADHD products.

Yom Chai's objective is to conduct scientific trials in Israel utilizing various Cannabinoid

and Terpene profiles with the goal of realizing multiple successful discoveries (outcomes). Yom Chai's goal is to bridge the gap between patients and doctors to bring scientifically validated products to market.

Scot Albert, COO of Yom Chai said, "We are excited to be working with Ofer Segal CEO and Yahav Blaicher Co-Founder of Kaneh-B to formulate, manufacture, and distribute world class Cannabis based products to the international marketplace."

About Yom Chai 

Yom Chai is collaborating with leading Israeli and American scientist and medical professionals to conduct scientific clinical trials in Israel targeting Autism, ADHD, Crohn's Disease, Psoriasis and Sleep Disorder to formulate, manufacture and distribute a wide range of Cannabis based products to treat various medical conditions. For more information visit us at www.yomchai.com

About Kaneh-B 

Founded in 2018, Kaneh- B is a research & development company which delivers clinical and pre-clinical CBD and natural compound-based products.

Kaneh-B's experts encompass 15 years of naturopathic blends and cannabis research. The company has developed a line of products, unique both in formulation and in method of application. These products envelop the Entourage effect with a unique combination of cannabinoids, terpenes and herbal compounds. 

Six products out of Kaneh-B's distinguished product line, have recently passed the five tests needed for the European dermal product approval. These products will soon be available in various European countries through an extensive network of distributors which Kaneh- B has already contracted with. For more information visit Kaneh-B at https://kaneh-b.com

For Further information contact: Lori Albert PR / Investor Relations lori@yomchai.com +1-206-496-4201

SOURCE Yom Chai



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store